From Boston Herald:
My small biopharma company is developing a drug to treat a rare, fatal and presently incurable disease that afflicts one in 70,000 children.
We are working around-the-clock to test our medicine and get it approved by the Food and Drug Administration. But our job just got much harder because of an unprecedented action by another government agency — the Centers for Medicare and Medicaid Services. Read the full article here
A mother is desperately seeking access to a trial drug for her nine-year-old son that she hopes could save his life. Severine Hamilton is trying to obtain a prototype enzyme replacement therapy for he
From Sanfilippo News: Allievex, a new clinical-stage biotechnology company founded by Pappas Capital, will continue the clinical program of BioMarin Pharmaceutical‘s tralesinidase alfa (formerly know
From PR Newswire: Allievex Corporation ("Allievex"), a clinical-stage biotechnology company founded by Pappas Capital, today announced the completion of a Series A financing co-led by Novo Holdings
